The End of the Pandemic Will Mean a Major Boost for These 2 Buy-and-Hold Stalwarts
It's no secret that in-person medical appointments are hard to come by in the age of COVID-19. But now that the U.S. appears to be getting the pandemic under control, people are eagerly flocking back to the clinic for everything they've put off, from dental cleanings to heart surgery.
Okay, perhaps some aren't exactly thrilled to be catching up on their deferred healthcare, but the ongoing influx of business is certainly going to drive the next few quarters of earnings across the industry. And, luckily for investors, there is a pair of reliable and rapidly growing medical device companies that are poised to benefit in a big way. Though neither of the two stocks are cheap at their present valuations, both could soar higher as life gets back on track, and that makes them worth a closer look.
Image source: Getty Images
Source Fool.com
